Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers

Authors

Sawa Ito, National Institutes of Health
Catherine M. Bollard, George Washington UniversityFollow
Mattias Carlsen, National Institutes of Health
J. Joseph Melenhorst, National Institutes of HealthFollow
Angelique Biancotto, National Institutes of Health
+17 additional authors

Document Type

Journal Article

Publication Date

7-2014

Journal

Molecular Therapy

Volume

Volume 22, Issue 7

Inclusive Pages

1388-1395

APA Citation

Ito, S., Bollard, C.M., Carlsten, M., Melenhorst, J.J., Biancotto, A. et al. (2014). Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory t cells and natural killer cells in healthy volunteers. Molecular Therapy, 22(7), 1388-1395.

Peer Reviewed

1